LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Jai Radhe Sales
03 1Acura Labs
04 2Alembic Pharmaceuticals Limited
05 1Anwita Drugs & Chemicals Pvt Ltd
06 1Apotex Pharmachem
07 1Asia Pioneer Pharmaceuticals
08 1Assia Chemical Industries Ltd
09 1AstraZeneca
10 2Aurobindo Pharma Limited
11 1Aurore Life Sciences
12 1CHEMO
13 1Chromo Laboratories
14 1Glochem Industries
15 1HELM Portugal
16 1Hetero Drugs
17 1Jiangsu Zhongbang Pharmaceutical Co, Ltd
18 2Jiangxi Synergy Pharmaceutical
19 1Jubilant Generics
20 1KOLON Life Science, Inc
21 1Krka
22 1Lek Pharmaceuticals
23 3Macleods Pharmaceuticals Limited
24 1Morepen Laboratories
25 1OUCHI SHINKO CHEMICAL INDUSTRIAL
26 1Parabolic Drugs
27 1Procos
28 1Quimica Sintetica
29 1RANBAXY LABORATORIES LIMITED
30 1Smilax Laboratories Limited
31 2Sun Pharmaceutical Industries Limited
32 1Suzhou Tianlu Bio-pharmaceutical Co., Ltd
33 2TAPI Technology & API Services
34 1Takeda Pharmaceutical
35 1Teva Pharmaceutical Industries
36 2Tianish Laboratories
37 1Titan Laboratories
38 1Torrent Pharmaceuticals Limited
39 2ULKAR KIMYA SANAYII VE TICARET
40 1Unimark Remedies Limited
41 2Viatris
42 2YUNGJIN PHARM. CO. LTD
43 1Zhejiang Hisun Chemical Co., Ltd.
44 1Zhejiang Huahai Pharmaceutical
45 1Zhejiang Kinglyuan Pharmaceutical
46 1Zhejiang Tianyu Pharmaceutical Co., Ltd
47 2Zhuhai Rundu Pharmaceutical
48 2Zydus Lifesciences
01 1Canada
02 10China
03 28India
04 4Israel
05 1Italy
06 2Japan
07 1Portugal
08 2Slovenia
09 3South Korea
10 2Spain
11 2Turkey
12 4U.S.A
13 1United Kingdom
01 10Active
02 12Inactive
03 39Blank
01 1Expired
02 16Valid
03 6Withdrawn by Holder
04 38Blank
01 1224MF10057
02 1224MF10142
03 1224MF10161
04 1224MF10225
05 1225MF10009
06 1225MF10094
07 1225MF10116
08 1225MF10143
09 1225MF10145
10 1225MF10168
11 1227MF10007
12 1227MF10168
13 1228MF10201
14 1230MF10146
15 1304MF10122
16 46Blank
01 1WC-0011nA2
02 1WC-0029
03 1WC-0041
04 1WC-0050A2
05 1WC-0079
06 1WC-0079A2
07 1WC-0079A3
08 1WC-0083
09 1WC-0095
10 2WC-0117
11 1WC-0119
12 1WC-0170
13 1WC-0317
14 1WC-0329
15 46Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22672
Submission : 2009-03-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25216
Submission : 2011-08-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26996
Submission : 2013-03-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20400
Submission : 2007-04-02
Status : Active
Type : II
Date of Issue : 2022-06-22
Valid Till : 2025-07-28
Written Confirmation Number : WC-0117
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24810
Submission : 2011-03-28
Status : Active
Type : II
Certificate Number : R1-CEP 2014-042 - Rev 01
Issue Date : 2023-01-16
Type : Chemical
Substance Number : 2573
Status : Valid
Date of Issue : 2019-11-28
Valid Till : 2022-07-02
Written Confirmation Number : WC-0079
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20053
Submission : 2006-12-18
Status : Inactive
Type : II
Registration Number : 225MF10145
Registrant's Address : Verovskova ulica 57, 1000 Ljubljana, Slovenia
Initial Date of Registration : 2013-07-25
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21374
Submission : 2008-05-21
Status : Inactive
Type : II
Certificate Number : R1-CEP 2011-204 - Rev 01
Issue Date : 2018-03-13
Type : Chemical
Substance Number : 2573
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25219
Submission : 2011-08-16
Status : Inactive
Type : II
We have 48 companies offering Candesartan Cilexetil
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?